Cibenzoline API Manufacturers

compare suppliers & get competitive offers

teaser-1024x654-1
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Cibenzoline is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Cibenzoline or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Cibenzoline API 53267-01-9?

Description:
Here you will find a list of producers, manufacturers and distributors of Cibenzoline. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Cibenzoline 
Synonyms:
Cifenline  
Cas Number:
53267-01-9 
DrugBank number:
DB13358 
Unique Ingredient Identifier:
Z7489237QT

General Description:

Cibenzoline is a chemical compound identified by the CAS number 53267-01-9. It is known for its distinct pharmacological properties and applications.

Classification:

Cibenzoline belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups, classified under the direct parent group Diphenylmethanes. This compound is a part of the Organic compounds, falling under the Benzenoids superclass, and categorized within the Benzene and substituted derivatives class, specifically within the Diphenylmethanes subclass.

Categories:

Cibenzoline is categorized under the following therapeutic classes: Antiarrhythmic agents, Antiarrhythmics, Class I, Antiarrhythmics, Class Ia, Cardiac Therapy, Cardiovascular Agents, Hypoglycemia-Associated Agents, Potential QTc-Prolonging Agents, QTc Prolonging Agents. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.